🇺🇸 Continuous Denosumab in United States

Continuous Denosumab (Continuous Denosumab) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Continuous Denosumab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Continuous Denosumab approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Continuous Denosumab in United States?

National Taiwan University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.